Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NAPROXEN\NAPROXEN Cause Treatment failure? 180 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 180 reports of Treatment failure have been filed in association with NAPROXEN\NAPROXEN. This represents 15.6% of all adverse event reports for NAPROXEN\NAPROXEN.

180
Reports of Treatment failure with NAPROXEN\NAPROXEN
15.6%
of all NAPROXEN\NAPROXEN reports
118
Deaths
150
Hospitalizations

How Dangerous Is Treatment failure From NAPROXEN\NAPROXEN?

Of the 180 reports, 118 (65.6%) resulted in death, 150 (83.3%) required hospitalization, and 161 (89.4%) were considered life-threatening.

Is Treatment failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NAPROXEN\NAPROXEN. However, 180 reports have been filed with the FAERS database.

What Other Side Effects Does NAPROXEN\NAPROXEN Cause?

Fatigue (502) Mobility decreased (467) Off label use (462) Fibromyalgia (456) Folliculitis (449) Joint swelling (448) Psoriatic arthropathy (445) Glossodynia (434) General physical health deterioration (433) Hand deformity (431)

What Other Drugs Cause Treatment failure?

METHOTREXATE (14,672) ETANERCEPT (11,893) ADALIMUMAB (9,990) ABATACEPT (9,301) RITUXIMAB (9,217) TOCILIZUMAB (9,097) HYDROXYCHLOROQUINE (8,786) LEFLUNOMIDE (8,686) INFLIXIMAB (8,535) SULFASALAZINE (7,423)

Which NAPROXEN\NAPROXEN Alternatives Have Lower Treatment failure Risk?

NAPROXEN\NAPROXEN vs NAPROXEN\PSEUDOEPHEDRINE NAPROXEN\NAPROXEN vs NAPROXEN\SUMATRIPTAN NAPROXEN\NAPROXEN vs NARATRIPTAN NAPROXEN\NAPROXEN vs NASONEX NAPROXEN\NAPROXEN vs NATALIZUMAB

Related Pages

NAPROXEN\NAPROXEN Full Profile All Treatment failure Reports All Drugs Causing Treatment failure NAPROXEN\NAPROXEN Demographics